Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
South & Central America Digital Pathology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnostics, Teleconsultation, and Training & Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics)
- Report Code : TIPRE00024452
- Pages : 151
The digital pathology market in South & Central America is expected to grow from US$ 64.74 million in 2022 to US$ 124.38 million by 2028. It is estimated to grow at a CAGR of 11.5% from 2022 to 2028.
Rising Use of Digital Pathology for Cancer Diagnosis Drives Digital Pathology Market in South & Central America
The use of digital pathology allows the in-depth diagnosis of tumors. Traditional pathology services can only help understand the location of tumor cells; this makes it difficult to share the cases for a second review. Digital cancer diagnosis typically involves scanning conventional glass slides to get successive images that are digitally united into a single, whole image that replicates the information on the glass slide. The pictures are combined together from associated clinical/hospitals or labs to provide an integrated picture of each unique cancer condition to the pathologists. Companies are launching new digital pathology tools and technologies for cancer detection. For instance, in January 2021, Roche launched the CE-IVD automated digital pathology algorithms that are capable of uPath HER2 Dual ISH image analysis and uPath HER2 (4B5) image analysis for breast cancer diagnosis, which also helps healthcare providers determine the best treatment strategy for each patient. Artificial intelligence (AI) is used in image analysis algorithms to assist pathologists in achieving quick and accurate patient diagnoses. Further, in May 2022, Hartford HealthCare launched a clinical research and innovation platform in collaboration with Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, to help clinicians deliver accurate diagnoses and enhanced care for patients suffering from breast cancer. In March 2022, Paige launched Paige Breast Lymph Node, a new AI software tool that helps pathologists in the detection of breast cancer that has metastasized to lymph nodes, concurrent with pathologists’ interpretive review. It is designed to improve diagnostic accuracy for the most subtle metastatic foci and has over 98% slide level sensitivity for the detection of metastases of any size. In the same month, Verily partnered with Lumea to combine its AI algorithms with Lumea’s comprehensive end-to-end digital pathology platform for developing products to diagnose and prognose prostate cancer, and provide guidance for selecting appropriate therapy for the same with improved efficiency and objectivity. Thus, with technological developments in cancer diagnostics, the use of digital solutions in the diagnosis of this disease is increasing, thereby fueling the digital pathology market growth.
Market Overview
The digital pathology market in South & Central America is bifurcated into Brazil and the rest of South & Central America. The market in Brazil is anticipated to grow with the highest rate during the forecast period owing to the increasing cancer cases in the country. In the last few years, cancer cases have increased in Brazil. Cancer is one of the major causes for mortality in the country. According to the Brazilian National Cancer Institute (INCA), it is estimated that Brazil will have around 600,000 new cases of cancer during 2018–2019. This rising cancer prevalence has translated into a 60% growth. According to Globocan, in 2020, the number of new cancer cases in Brazil was 592,212. Prostate cancer is the most common cancer in the country. There were 97,278 (16.4%) cases of Prostate cancer in Brazil in 2020. Similarly, 88,492 (14.9%) number of new cases of breast cancer, 55,102 (9.3%) cases of colorectum cancer, 40,409 (6.8%) cases of lung cancer, 30,607 (5.2%) cases of thyroid cancer, and 280,324 (47.3) cases of other cancers were recorded in Brazil. The rising incidence of cancer, together with the growing awareness about the benefits of medical imaging for cancer treatment in Brazil. Digital pathology solution is a major diagnostic tool for cancer patients. It enhances cancer diagnosis. Thus, increase in cancer cases will surge the deployment and integration of digital pathology solutions. Also, the rising prevalence of cancer in Brazil is expected to boost the development of novel products during the forecast years. Thus, the increasing cancer cases in Brazil bolster the digital pathology market growth in South & Central America.
South & Central America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Digital Pathology Market Segmentation
The South & Central America digital pathology Market is segmented into product , type , application and end user.
Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment registered the largest market share in 2022. Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held the larger market share in 2022. Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the larger market share in 2022. Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The pharma and biotech companies segment held the largest market share in 2022. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022. Koninklijke Philips N.V.; Nikon Corporation; PerkinElmer, Inc.; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F.Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation; are the leading companies operating in the digital pathology in the region.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Digital Pathology Market – By Product
1.3.2 South & Central America Digital Pathology Market – By Type
1.3.3 South & Central America Digital Pathology Market – By Application
1.3.4 South & Central America Digital Pathology Market – By End User
1.3.5 South & Central America Digital Pathology Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Digital Pathology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Experts Opinion
5. South & Central America Digital Pathology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Technological Advancements in Digital Pathology Systems
5.1.2 Growing Preference for Telepathology in Remote Areas
5.1.3 Use of Digital Pathology for Cancer Diagnosis
5.2 Market Restraints
5.2.1 High Cost of Digital Pathology Systems
5.2.2 Shortage of Skilled Professionals to Operate Digital Pathology Systems
5.3 Market Opportunities
5.3.1 Use of Digital Pathology in Drug Development
5.4 Future Trends
5.4.1 Use of Artificial Intelligence
5.5 Impact Analysis
6. Digital Pathology Market – South & Central America Analysis
6.1 South & Central America Digital Pathology Market Revenue Forecast and Analysis
7. South & Central America Digital Pathology Market Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 South & Central America Digital Pathology Market, By Product 2022 & 2028 (%)
7.2.1 South and Central America Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
7.2.2 South and Central America Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
7.3 Scanners
7.3.1 Overview
7.3.2 South & Central America Scanners Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Integrated
7.3.3.1 Overview
7.3.3.2 South & Central America Integrated Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Standalone
7.3.4.1 Overview
7.3.4.2 South & Central America Standalone Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Software
7.4.1 Overview
7.4.2 South & Central America Software Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Communication System
7.5.1 Overview
7.5.2 South & Central America Communication System Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Storage
7.6.1 Overview
7.6.2 South & Central America Storage Market Revenue and Forecast to 2028 (US$ Mn)
8. South & Central America Digital Pathology Market Analysis – by Type
8.1 Overview
8.2 South & Central America Digital Pathology Market Revenue Share, by Type (2022 and 2028)
8.2.1.1 South and Central America: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
8.3 Human Pathology
8.3.1 Overview
8.3.2 South & Central America Human Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Veterinary Pathology
8.4.1 Overview
8.4.2 South & Central America Veterinary Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Digital Pathology Market Analysis – by Application
9.1 Overview
9.2 South & Central America Digital Pathology Market, By Application 2022 & 2028 (%)
9.2.1 South and Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 South & Central America Drug Discovery Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Disease Diagnostics
9.4.1 Overview
9.4.2 South & Central America Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Teleconsultation
9.5.1 Overview
9.5.2 South & Central America Teleconsultation Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Training and Education
9.6.1 Overview
9.6.2 South & Central America Training and Education Market Revenue and Forecast to 2028 (US$ Mn)
10. South & Central America Digital Pathology Market Analysis – by End User
10.1 Overview
10.2 South & Central America Digital Pathology Market Revenue Share, by End User (2022 and 2028)
10.2.1 South and Central America: Digital Pathology Market, by End user – Revenue and Forecast to 2028 (US$ Million)
10.3 Pharma and Biotech Companies
10.3.1 Overview
10.3.2 South & Central America Pharma and Biotech Companies: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospital
10.4.1 Overview
10.4.2 South & Central America Hospital: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Academic
10.5.1 Overview
10.5.2 South & Central America Academic: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Digital Pathology Market Revenue and Forecast to 2028– by Country
11.1 South and Central America Digital Pathology Market
11.1.1 Overview
11.1.3 South and Central America: Digital Pathology Market, by Country, 2022 & 2028 (%)
11.1.3.1 Brazil: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.1.1 Overview
11.1.3.1.2 Brazil Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
11.1.3.1.3 Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
11.1.3.1.4 Brazil: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
11.1.3.1.4.1 Brazil: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
11.1.3.1.5 Brazil: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.1.3.1.6 Brazil: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
11.1.3.2 Argentina: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.2.1 Overview
11.1.3.2.2 Argentina Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
11.1.3.2.3 Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
11.1.3.2.4 Argentina: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
11.1.3.2.4.1 Argentina: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
11.1.3.2.5 Argentina: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.1.3.2.6 Argentina: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
11.1.3.3 Rest of the South and Central America: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.3.1 Overview
11.1.3.3.2 Rest of the South and Central America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
11.1.3.3.3 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
11.1.3.3.4 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
11.1.3.3.5 Rest of South & Central America: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
11.1.3.3.6 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.1.3.3.7 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
12. South & Central America Digital Pathology Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the South & Central America Digital Pathology Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Koninklijke Philips N.V.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nikon Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 PerkinElmer, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 3DHISTECH Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hamamatsu Photonics K.K.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Visiopharm A/S
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Glencoe Software, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms, Digital Pathology Market
LIST OF TABLES
Table 1. South and Central America Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 2. South and Central America Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
Table 3. South and Central America: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. South and Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5. South and Central America: Digital Pathology Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 7. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
Table 8. Brazil: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
Table 11. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 12. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
Table 13. Argentina: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 15. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
Table 16. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
Table 18. Rest of South & Central America: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 20. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
Table 21. Organic Developments in the South & Central America Digital Pathology Market
Table 22. Inorganic Developments in the South & Central America Digital Pathology Market
Table 23. Glossary of Terms, Digital Pathology Market
LIST OF FIGURES
Figure 1. South & Central America Digital Pathology Market Segmentation
Figure 2. South & Central America Digital Pathology Market, By Country
Figure 3. South & Central America Digital Pathology Market Overview
Figure 4. Scanners Segment Held Largest Share of Product Segment in South & Central America Digital Pathology Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Digital Pathology Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. South & Central America Digital Pathology Market, by Product 2022 & 2028 (%)
Figure 11. South & Central America Scanners Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. South & Central America Integrated Market Revenue and Forecasts To 2028 (US$ MN)
Figure 13. South & Central America Standalone Market Revenue and Forecasts To 2028 (US$ MN)
Figure 14. South & Central America Software Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. South & Central America Communication System Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. South & Central America Storage Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. South & Central America Digital Pathology Market Revenue Share, by Type (2022 and 2028)
Figure 18. South & Central America Human Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Veterinary Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. South & Central America Digital Pathology Market, by Application 2022 & 2028 (%)
Figure 21. South & Central America Drug Discovery Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. South & Central America Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. South & Central America Teleconsultation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. South & Central America Training and Education Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Pathology Market Revenue Share, by End User (2022 and 2028)
Figure 26. South & Central America Pharma and Biotech Companies: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South & Central America Hospital: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America Academic: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. South and Central America Digital Pathology Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 30. South and Central America: Digital Pathology Market, by Country, 2022 & 2028 (%)
Figure 31. Brazil: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Argentina: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of the South and Central America: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies in the South & Central America Digital Pathology Market (%)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Digital Pathology Market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in South & Central America Digital Pathology Market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – South & Central America Digital Pathology Market
● Koninklijke Philips N.V.
● Nikon Corporation
● PerkinElmer, Inc.
● 3DHISTECH Ltd.
● Hamamatsu Photonics K.K.
● F. Hoffmann-La Roche Ltd
● Visiopharm A/S
● Glencoe Software, Inc.
● Danaher Corporation
At 9.8% CAGR, the South & Central America Digital Pathology Market is speculated to be worth US$ 124.38 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the South & Central America digital pathology market was valued at US$ 64.74 million in 2022 and is expected to reach US$ 124.38 million by 2028, registering an annual growth rate of 9.8% from 2022 to 2028. Technological advancements in digital pathology systems, growing preference for telepathology in remote areas and digital pathology for cancer are the critical factors attributed to the market expansion.
Computerization, robotic light microscopy, multiple fiber-optic communications, and digital imaging are among the technologies contributing to the modernization of digital pathology. Healthcare information technology (IT) helps physicians in maintaining optimal workflow, along with allowing them to meet the continuously changing patient expectations. The Aperio ePathAccess software offered by Leica Biosystems enables users to share digital pathology images and case data with experts outside the IT network. Further, frequent advancements in whole-slide imaging (WSI) technology, software applications, LIS/LIMS interface, and high-speed networking are allowing pathologists to fully integrate digital pathology into their workflows. Further, the growing use of microarrays and predictive models, such as API algorithms and hybrid models, is bolstering the demand for digital image analysis. A computer-aided diagnosis integrates image processing with the concepts of physics and mathematics, and computational algorithms for disease diagnosis, anatomical evaluation, and disease progression quantification and risk assessment. Thus, the increasing popularity of computer-aided systems is supporting the digital pathology market growth.
On the contrary, high cost of digital pathology systems hampers market South & Central America digital pathology market.
Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment held 55.40% market share in 2022, amassing US$ 35.87 million. It is projected to garner US$ 68.12 million by 2028 to expand at 11.3% CAGR during 2022–2028. Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held 66.22% market share in 2022, amassing US$ 42.87 million. It is projected to garner US$ 84.10 million by 2028 to expand at 11.9% CAGR during 2022–2028. Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held 37.16% market share in 2022, amassing US$ 24.05 million. It is projected to garner US$ 47.37 million by 2028 to expand at 12.0% CAGR during 2022–2028. Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The pharma and biotech companies segment held 53.59% market share in 2022, amassing US$ 34.69 million. It is projected to garner US$ 67.89 million by 2028 to expand at 11.8% CAGR during 2022–2028. Based on country, the South & Central America digital pathology market has been categorized into Brazil, Argentina, and Rest of South & Central America. Our regional analysis states Brazil captured 62.13% market share in 2022. It was assessed at US$ 40.22 million in 2022 and is likely to hit US$ 78.49 million by 2028, exhibiting a CAGR of 11.8% during the forecast period. Key players dominating the South & Central America digital pathology market are Koninklijke Philips N.V.; Nikon Corporation; PerkinElmer, Inc.; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F.Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation.
In July,2022; F. Hoffmann-La Roche Ltd launched its high-capacity slide scanner, VENTANA DP 600 which produces high-resolution, digital images of stained tissue samples to help in the diagnosis of cancer and determine a patient’s treatment. The technologically advanced product has empowered the digital transformation of pathology and enable better, more personalized healthcare. In October,2021; Koninklijke Philips N.V. launched its next-generation digital pathology solution, IntelliSite to assist pathologists in diagnosing and creating care pathways.
Related Reports
- $3,000.00 – $5,000.00
